165 related articles for article (PubMed ID: 33843013)
1. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
[TBL] [Abstract][Full Text] [Related]
2. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
Secinti IE; Ozgur T; Gursoy D; Dede I
APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
[TBL] [Abstract][Full Text] [Related]
3. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
[TBL] [Abstract][Full Text] [Related]
5. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
[TBL] [Abstract][Full Text] [Related]
10. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
Neppl C; Zlobec I; Schmid RA; Berezowska S
Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
[TBL] [Abstract][Full Text] [Related]
11. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumour budding in stomach cancers.
Kucuk S
Int J Clin Pract; 2021 Dec; 75(12):e14922. PubMed ID: 34580963
[TBL] [Abstract][Full Text] [Related]
13. Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients.
Zlobec I; Dawson HE; Blank A; Bokhorst JM; Berger MD; Nagtegaal ID; Lugli A
Eur J Cancer; 2020 May; 130():139-145. PubMed ID: 32200222
[TBL] [Abstract][Full Text] [Related]
14. Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
Jesinghaus M; Schmitt M; Lang C; Reiser M; Scheiter A; Konukiewitz B; Steiger K; Silva M; Tschurtschenthaler M; Lange S; Foersch S; Becker KF; Saur D; Friess H; Halfter K; Engel J; Boxberg M; Pfarr N; Wilhelm D; Weichert W
Am J Surg Pathol; 2021 Jul; 45(7):969-978. PubMed ID: 34105518
[TBL] [Abstract][Full Text] [Related]
15. Taking tumour budding to the next frontier - a post International Tumour Budding Consensus Conference (ITBCC) 2016 review.
Studer L; Blank A; Bokhorst JM; Nagtegaal ID; Zlobec I; Lugli A; Fischer A; Dawson H
Histopathology; 2021 Mar; 78(4):476-484. PubMed ID: 33001500
[TBL] [Abstract][Full Text] [Related]
16. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
17. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
Lohneis P; Hieggelke L; Gebauer F; Ball M; Bruns C; Büttner R; Löser H; Quaas A
Virchows Arch; 2021 Mar; 478(3):393-400. PubMed ID: 32761393
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
[TBL] [Abstract][Full Text] [Related]
19. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
[TBL] [Abstract][Full Text] [Related]
20. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
Haddad TS; Lugli A; Aherne S; Barresi V; Terris B; Bokhorst JM; Brockmoeller SF; Cuatrecasas M; Simmer F; El-Zimaity H; Fléjou JF; Gibbons D; Cathomas G; Kirsch R; Kuhlmann TP; Langner C; Loughrey MB; Riddell R; Ristimäki A; Kakar S; Sheahan K; Treanor D; van der Laak J; Vieth M; Zlobec I; Nagtegaal ID
Virchows Arch; 2021 Sep; 479(3):459-469. PubMed ID: 33650042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]